"Agitation" Claim For Psychotropic Drugs May Be Considered By FDA

FDA may propose "agitation" as an indication for psychotropic drugs at the March 9 Psychopharmacologic Drugs Advisory Committee meeting on psychiatric and behavioral disturbances associated with dementia.